1. Home
  2. ELEV vs HOLO Comparison

ELEV vs HOLO Comparison

Compare ELEV & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • HOLO
  • Stock Information
  • Founded
  • ELEV 2019
  • HOLO 2018
  • Country
  • ELEV United States
  • HOLO China
  • Employees
  • ELEV N/A
  • HOLO N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • ELEV Health Care
  • HOLO Technology
  • Exchange
  • ELEV Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • ELEV 22.6M
  • HOLO 24.9M
  • IPO Year
  • ELEV 2021
  • HOLO N/A
  • Fundamental
  • Price
  • ELEV $0.38
  • HOLO $7.09
  • Analyst Decision
  • ELEV Hold
  • HOLO
  • Analyst Count
  • ELEV 6
  • HOLO 0
  • Target Price
  • ELEV $1.77
  • HOLO N/A
  • AVG Volume (30 Days)
  • ELEV 938.5K
  • HOLO 4.2M
  • Earning Date
  • ELEV 08-05-2025
  • HOLO 01-01-0001
  • Dividend Yield
  • ELEV N/A
  • HOLO N/A
  • EPS Growth
  • ELEV N/A
  • HOLO N/A
  • EPS
  • ELEV N/A
  • HOLO N/A
  • Revenue
  • ELEV N/A
  • HOLO $39,771,750.00
  • Revenue This Year
  • ELEV N/A
  • HOLO N/A
  • Revenue Next Year
  • ELEV N/A
  • HOLO N/A
  • P/E Ratio
  • ELEV N/A
  • HOLO N/A
  • Revenue Growth
  • ELEV N/A
  • HOLO 42.62
  • 52 Week Low
  • ELEV $0.22
  • HOLO $4.16
  • 52 Week High
  • ELEV $3.28
  • HOLO $608.00
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 54.73
  • HOLO 53.39
  • Support Level
  • ELEV $0.36
  • HOLO $4.84
  • Resistance Level
  • ELEV $0.38
  • HOLO $6.20
  • Average True Range (ATR)
  • ELEV 0.01
  • HOLO 0.46
  • MACD
  • ELEV -0.00
  • HOLO 0.37
  • Stochastic Oscillator
  • ELEV 53.93
  • HOLO 91.11

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

Share on Social Networks: